Departments and specialties

Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work together to ensure quality care and successful recovery.

Research

Doctors and scientists at Mayo Clinic are studying ways to predict breast cancer risk. For those with a high risk of cancer, researchers are studying ways to reduce the risk that breast cancer will develop and ways to use imaging tests to detect breast cancer early.

Mayo Clinic is one of a select group of medical centers in the United States to be recognized as a Specialized Program of Research Excellence (SPORE) for breast cancer research, funded by the National Cancer Institute.

Cancer research is conducted in coordination with Mayo Clinic Comprehensive Cancer Center. Mayo Clinic Comprehensive Cancer Center receives funding from the National Cancer Institute and is designated as a Comprehensive Cancer Center. This designation recognizes the institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.

Publications

See a list of publications by Mayo Clinic authors on breast cancer risk assessment on PubMed, a service of the National Library of Medicine.

Research Profiles

Jan. 25, 2025
  1. Elmore JG, et al. Screening for breast cancer: Strategies and recommendations. https://www.uptodate.com/contents/search. Accessed Nov. 16, 2024.
  2. U.S. Preventive Services Task Force. Risk assessment, genetic counseling and genetic testing for BRCA-related cancer. JAMA. 2019; doi:10.1001/jama.2019.10987.
  3. Klassen CL, et al. Breast cancer risk evaluation for the primary care physician. Cleveland Clinic Journal of Medicine. 2022; doi:10.3949/ccjm.89a.21023.
  4. Breast cancer risk reduction. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=2&id=1420. Accessed Nov. 16, 2024.
  5. Breast SPOREs. National Cancer Institute. https://trp.cancer.gov/spores/breast.htm. Accessed Nov. 16, 2024.
  6. Member institutions. Alliance for Trials in Clinical Oncology. https://www.allianceforclinicaltrialsinoncology.org/main/public/standard.xhtml?path=%2FPublic%2FInstitutions. Accessed Nov. 16, 2024.
  7. Patel BK, et al. Prospective study of supplemental screening with contrast-enhanced mammography in women with elevated risk of breast cancer: Results of the prevalence round. Journal of Clinical Oncology. 2024; doi:10.1200/JCO.22.02819.
  8. Pruthi S (expert opinion). Mayo Clinic. Nov. 25, 2024.

Breast cancer risk assessment